IBA announced it has signed the final contract with Medtechnica Ltd. for the installation of two Proteus®?ONE1compact proton therapy solutions at the Sourasky Medical Center (Ichilov Hospital) in Tel Aviv, Israel. This follows the signature of a binding term sheet previously announced in May 2023. Sourasky Medical Center has been selected by the Israeli Ministry of Health to host the first national proton therapy center in Israel, bringing this cutting-edge technology to hundreds of patients per year.

The project is fully financed and IBA received the first payment in July 2023. The integrated solution also includes a fully integrated quality assurance (QA) hardware and software package from IBA Dosimetry. Once approved by regulatory authorities, IBA will upgrade the two systems with DynamicARC®?2, IBA's unique Arc Proton Therapy solution.

The contract includes long-term operation and maintenance services to be provided by IBA.